UPLOAD Filing
Silo Pharma, Inc.
Date: April 17, 2025 · CIK: 0001514183 · Accession: 0000000000-25-004102
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Silo Pharma, Inc. Draft Registration Statement on Form S-1 Submitted April 11, 2025 CIK No. 0001514183 Dear Eric Weisblum:
April 17, 2025
Eric Weisblum Chief Executive Officer Silo Pharma, Inc. 677 N. Washington Boulevard Sarasota, FL 34236
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Richard Friedman, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 17, 2025 Eric Weisblum Chief Executive Officer Silo Pharma, Inc. 677 N. Washington Boulevard Sarasota, FL 34236 Re: Silo Pharma, Inc. Draft Registration Statement on Form S-1 Submitted April 11, 2025 CIK No. 0001514183 Dear Eric Weisblum: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Richard Friedman, Esq. </TEXT> </DOCUMENT>